Free Trial
NYSE:NSPR

InspireMD (NSPR) Stock Price, News & Analysis

InspireMD logo
$2.44 +0.02 (+0.83%)
Closing price 04:00 PM Eastern
Extended Trading
$2.44 0.00 (0.00%)
As of 05:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About InspireMD Stock (NYSE:NSPR)

Key Stats

Today's Range
$2.41
$2.47
50-Day Range
$2.22
$2.79
52-Week Range
$1.99
$3.80
Volume
32,601 shs
Average Volume
103,146 shs
Market Capitalization
$101.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.50
Consensus Rating
Buy

Company Overview

InspireMD Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

NSPR MarketRank™: 

InspireMD scored higher than 68% of companies evaluated by MarketBeat, and ranked 329th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InspireMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    InspireMD has received no research coverage in the past 90 days.

  • Read more about InspireMD's stock forecast and price target.
  • Earnings Growth

    Earnings for InspireMD are expected to grow in the coming year, from ($0.79) to ($0.73) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InspireMD is -3.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InspireMD is -3.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    InspireMD has a P/B Ratio of 1.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.72% of the float of InspireMD has been sold short.
  • Short Interest Ratio / Days to Cover

    InspireMD has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InspireMD has recently decreased by 16.31%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    InspireMD does not currently pay a dividend.

  • Dividend Growth

    InspireMD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.72% of the float of InspireMD has been sold short.
  • Short Interest Ratio / Days to Cover

    InspireMD has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InspireMD has recently decreased by 16.31%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for InspireMD this week, compared to 2 articles on an average week.
  • Search Interest

    4 people have searched for NSPR on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added InspireMD to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InspireMD insiders have bought more of their company's stock than they have sold. Specifically, they have bought $249,996.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    29.72% of the stock of InspireMD is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    44.78% of the stock of InspireMD is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about InspireMD's insider trading history.
Receive NSPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InspireMD and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NSPR Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
InspireMD Rings the Closing Bell
Contrasting InfuSystem (NYSE:INFU) & InspireMD (NYSE:NSPR)
InspireMD, Inc. (NSPR) Q2 2025 Earnings Call Transcript
See More Headlines

NSPR Stock Analysis - Frequently Asked Questions

InspireMD's stock was trading at $2.63 on January 1st, 2025. Since then, NSPR stock has decreased by 7.8% and is now trading at $2.4250.

InspireMD, Inc. (NYSE:NSPR) posted its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.20) by $0.04. The firm earned $1.81 million during the quarter, compared to analyst estimates of $1.74 million. InspireMD had a negative net margin of 413.96% and a negative trailing twelve-month return on equity of 69.42%.

InspireMD's top institutional shareholders include Rosalind Advisors Inc. (5.49%), Soleus Capital Management L.P. (4.52%), Huntleigh Advisors Inc. (0.41%) and Raymond James Financial Inc. (0.11%). Insiders that own company stock include Marvin Slosman, Gary S Roubin, Paul Stuka and Thomas J Kester.
View institutional ownership trends
.

Shares of NSPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InspireMD investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Disc Medicine (IRON), Jabil (JBL), Adobe (ADBE) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
11/12/2024
Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NYSE:NSPR
CIK
1433607
Fax
N/A
Employees
50
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$4.00
Potential Upside/Downside
+85.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.83)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.92 million
Net Margins
-413.96%
Pretax Margin
-413.00%
Return on Equity
-69.42%
Return on Assets
-57.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.39
Quick Ratio
6.05

Sales & Book Value

Annual Sales
$7.07 million
Price / Sales
14.32
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.83 per share
Price / Book
1.33

Miscellaneous

Outstanding Shares
41,721,000
Free Float
18,332,000
Market Cap
$101.17 million
Optionable
Optionable
Beta
0.60
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NYSE:NSPR) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners